Skip to main content

Table 2 Report characteristics of incorporating system evaluation

From: Non-pharmacological interventions for smoking cessation: analysis of systematic reviews and meta-analyses

Project

Category

Number of studies (%)

Study

Quantitative synthesis

104(71.72)

Qualitative synthesis

41(28.28)

Year

2021–2022

25(17.24)

2016–2020

54(37.24)

2011–2015

32(22.07)

2006–2010

20(13.79)

2000–2005

11(7.59)

–1999

3(0.69)

Country

UK

47(32.41)

US

35(24.14)

Australia

19(13.10)

Canada

8(5.52)

China

9(6.21)

Germany

4(2.76)

South Korea

4(2.76)

Netherlands

3(2.07)

India

3(2.07)

New Zealand

2(1.38)

Austria

2(1.38)

Spain

2(1.38)

Othera

6(4.14)

Population

General populations

108(74.48)

Special populations

22(15.17)

Vulnerable populations

8(5.52)

Other populationsb

7(4.83)

Intervention

Cognitive behavioural education

32(22.07)

Professional advice

20(13.79)

Non-nicotine e-cigarettes

13(8.97)

Internet interventions

9(6.21)

Smokeless policy

7(4.83)

Telephone and SMS counseling

7(4.83)

Group support

7(4.83)

Acupuncture

9(6.21)

Game incentives

4(2.76)

Motive interview

4(2.76)

Exercise

10(6.87)

Mixed psychological intervention

3(2.07)

Quit smoking Application (App)

4(2.76)

Money incentives

3(2.07)

Brain stimulation

4(2.76)

Self-help programs

3(2.07)

Meditation

3(2.07)

Otherc

3(2.07)

  1. aOther countries that published only one study: Denmark, Malaysia, Norway, Thailand, Iran, and Italy
  2. bOther populations involved in only one study: cancer patients, coronary heart disease (CHD), elderly, schoolgirls, and patients with cardiovascular disease
  3. cOther interventions involving only one study: hypnotherapy, smoking reduction, and aversion therapy